12 results
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
SARS-CoV-2, the virus ... causing COVID-19 ... #Pharmacology #Treatment ... #Virus #Antiviral ... #Management #Ivermectin
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
as data on new treatment ... Nomenclature (NOT "Wuhan Virus ... COVID-19 • Virus ... Cheatsheet #Diagnosis #Management ... #Summary #SARSCoV2
COVID-19 - How does it affect you? 
Gas Exchange 
Each sac of air, or alveolus, is
COVID-19 - How does ... , allowing the virus ... copies of the virus ... #Pathophysiology ... #SARSCOV2 #PatientInfo
COVID19 - Community Mitigation Strategy
In the 1st (steepest) curve, virus reproduces quickly in a short period
COVID19 - Community ... steepest) curve, virus ... receive better treatment ... SocialDistancing #Management ... #Policy #SARSCoV2
Remdesivir (GS-5734) - manufactured by Gilead Sciences
Remdesivir blocks the replication of viruses by inserting into the
replication of the virus ... #Pharmacology #Pathophysiology ... #COVID19 #SARSCOV2
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... Immunodeficiency Virus ... Meningoencephalitis #IDSA #Treatment ... #management #meningitis ... #cryptococcus #HIVAIDS
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
, Epstein-Barr virus ... immunodeficiency virus ... HIV), and Zika virus ... the underlying pathophysiology ... and cauda equina TREATMENT
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Pathophysiology ... like illnesses, COVID ... 19 - Zika virus ... Syndrome #diagnosis #management ... #treatment #neurology
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Lymphohistiocytosis (HLH) Pathophysiology ... Infections+++: Virus ... Unknown cause Treatment ... Lymphohistiocytosis #diagnosis #management ... #treatment #summary
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
Herpes Simplex Virus ... • Continue treatment ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS